Literature DB >> 19653005

The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes.

Ildus I Ahmetov1, Alun G Williams, Daniil V Popov, Ekaterina V Lyubaeva, Albina M Hakimullina, Olga N Fedotovskaya, Irina A Mozhayskaya, Olga L Vinogradova, Irina V Astratenkova, Hugh E Montgomery, Viktor A Rogozkin.   

Abstract

Endurance performance is a complex phenotype subject to the influence of both environmental and genetic factors. Although the last decade has seen a variety of specific genetic factors proposed, many in metabolic pathways, each is likely to make a limited contribution to an 'elite' phenotype: it seems more likely that such status depends on the simultaneous presence of multiple such variants. The aim of the study was to investigate individually and in combination the association of common metabolic gene polymorphisms with endurance athlete status, the proportion of slow-twitch muscle fibers and maximal oxygen consumption. A total of 1,423 Russian athletes and 1,132 controls were genotyped for 15 gene polymorphisms, of which most were previously reported to be associated with athlete status or related intermediate phenotypes. Muscle fiber composition of m. vastus lateralis in 45 healthy men was determined by immunohistochemistry. Maximal oxygen consumption of 50 male rowers of national competitive standard was determined during an incremental test to exhaustion on a rowing ergometer. Ten 'endurance alleles' (NFATC4 Gly160, PPARA rs4253778 G, PPARD rs2016520 C, PPARGC1A Gly482, PPARGC1B 203Pro, PPP3R1 promoter 5I, TFAM 12Thr, UCP2 55Val, UCP3 rs1800849 T and VEGFA rs2010963 C) were first identified showing discrete associations with elite endurance athlete status. Next, to assess the combined impact of all 10 gene polymorphisms, all athletes were classified according to the number of 'endurance' alleles they possessed. The proportion of subjects with a high (≥9) number of 'endurance' alleles was greater in the best endurance athletes compared with controls (85.7 vs. 37.8%, P = 7.6 × 10(-6)). The number of 'endurance' alleles was shown to be positively correlated (r = 0.50; P = 4.0 × 10(-4)) with the proportion of fatigue-resistant slow-twitch fibers, and with maximal oxygen consumption (r = 0.46; P = 7.0 × 10(-4)). These data suggest that the likelihood of becoming an elite endurance athlete depends on the carriage of a high number of endurance-related alleles.

Entities:  

Mesh:

Year:  2009        PMID: 19653005     DOI: 10.1007/s00439-009-0728-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  62 in total

Review 1.  Emerging technologies in DNA sequencing.

Authors:  Michael L Metzker
Journal:  Genome Res       Date:  2005-12       Impact factor: 9.043

2.  Genome-wide linkage scan for athlete status in 700 British female DZ twin pairs.

Authors:  Marleen H M De Moor; Tim D Spector; Lynn F Cherkas; Mario Falchi; Jouke Jan Hottenga; Dorret I Boomsma; Eco J C De Geus
Journal:  Twin Res Hum Genet       Date:  2007-12       Impact factor: 1.587

Review 3.  Genes, athlete status and training -- An overview.

Authors:  Ildus I Ahmetov; Viktor A Rogozkin
Journal:  Med Sport Sci       Date:  2009-08-17

4.  [Association of regulatory genes polymorphisms with aerobic and anaerobic performance of athletes].

Authors:  I I Akhmetov; D V Popov; I A Mozhaĭskaia; S S Missina; I V Astratenkova; O L Vinogradova; V A Rogozkin
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2007-08

5.  Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake.

Authors:  Markku Vänttinen; Pirjo Nuutila; Teemu Kuulasmaa; Jussi Pihlajamäki; Kirsti Hällsten; Kirsi A Virtanen; Riikka Lautamäki; Pauliina Peltoniemi; Teemu Takala; Antti P M Viljanen; Juhani Knuuti; Markku Laakso
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

6.  Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population.

Authors:  D J Halsall; J Luan; P Saker; S Huxtable; I S Farooqi; J Keogh; N J Wareham; S O'Rahilly
Journal:  Int J Obes Relat Metab Disord       Date:  2001-04

7.  PPARalpha gene variation and physical performance in Russian athletes.

Authors:  Ildus I Ahmetov; Irina A Mozhayskaya; David M Flavell; Irina V Astratenkova; Antonina I Komkova; Ekaterina V Lyubaeva; Pavel P Tarakin; Boris S Shenkman; Anastasia B Vdovina; Aleksei I Netreba; Daniil V Popov; Olga L Vinogradova; Hugh E Montgomery; Viktor A Rogozkin
Journal:  Eur J Appl Physiol       Date:  2006-02-28       Impact factor: 3.078

Review 8.  What makes a champion? Explaining variation in human athletic performance.

Authors:  Tom D Brutsaert; Esteban J Parra
Journal:  Respir Physiol Neurobiol       Date:  2006-01-30       Impact factor: 1.931

Review 9.  Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.

Authors:  Philippe Lefebvre; Giulia Chinetti; Jean-Charles Fruchart; Bart Staels
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

10.  Mitochondrial transcription factor A regulates mtDNA copy number in mammals.

Authors:  Mats I Ekstrand; Maria Falkenberg; Anja Rantanen; Chan Bae Park; Martina Gaspari; Kjell Hultenby; Pierre Rustin; Claes M Gustafsson; Nils-Göran Larsson
Journal:  Hum Mol Genet       Date:  2004-03-11       Impact factor: 6.150

View more
  33 in total

Review 1.  Genes and elite athletes: a roadmap for future research.

Authors:  Nir Eynon; Jonatan R Ruiz; José Oliveira; José Alberto Duarte; Ruth Birk; Alejandro Lucia
Journal:  J Physiol       Date:  2011-05-03       Impact factor: 5.182

2.  Genes and Elite Marathon Running Performance: A Systematic Review.

Authors:  Hannah J Moir; Rachael Kemp; Dirk Folkerts; Owen Spendiff; Cristina Pavlidis; Elizabeth Opara
Journal:  J Sports Sci Med       Date:  2019-08-01       Impact factor: 2.988

3.  Association between the PPARa and PPARGCA gene variations and physical performance in non-trained male adolescents.

Authors:  Farzad Zehsaz; Hamed Abbasi Soltani; Roya Hazrati; Negin Farhangi; Amir Monfaredan; Mehri Ghahramani
Journal:  Mol Biol Rep       Date:  2018-10-15       Impact factor: 2.316

4.  PPAR-α and PPARGC1A gene variants have strong effects on aerobic performance of Turkish elite endurance athletes.

Authors:  Ercan Tural; Nurten Kara; Seydi Ahmet Agaoglu; Mehmet Elbistan; Mehmet Yalcin Tasmektepligil; Osman Imamoglu
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

5.  ACE I/D, ACTN3 R577X, PPARD T294C and PPARGC1A Gly482Ser polymorphisms and physical fitness in Taiwanese late adolescent girls.

Authors:  Li-Ling Chiu; Tzu-Wen Chen; Sandy S Hsieh; Ling-Ling Hsieh
Journal:  J Physiol Sci       Date:  2012-01-14       Impact factor: 2.781

6.  HIF1A P582S gene association with endurance training responses in young women.

Authors:  J S McPhee; J Perez-Schindler; H Degens; D Tomlinson; P Hennis; K Baar; A G Williams
Journal:  Eur J Appl Physiol       Date:  2011-02-23       Impact factor: 3.078

7.  Genetics and the Elite Athlete: Our Understanding in 2020.

Authors:  Rakesh John; Mandeep Singh Dhillon; Sidak Dhillon
Journal:  Indian J Orthop       Date:  2020-03-11       Impact factor: 1.251

Review 8.  Genetic influences in sport and physical performance.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-10-01       Impact factor: 11.136

Review 9.  Genes for elite power and sprint performance: ACTN3 leads the way.

Authors:  Nir Eynon; Erik D Hanson; Alejandro Lucia; Peter J Houweling; Fleur Garton; Kathryn N North; David J Bishop
Journal:  Sports Med       Date:  2013-09       Impact factor: 11.136

10.  The GABPB1 gene A/G polymorphism in Polish rowers.

Authors:  A Maciejewska-Karłowska; A Leońska-Duniec; P Cięszczyk; M Sawczuk; J Eider; K Ficek; S Sawczyn
Journal:  J Hum Kinet       Date:  2012-04-03       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.